Apoquel 5,4 mg comprimés pelliculés pour chiens

About this veterinary medicine

Apoquel 5,4 mg comprimés pelliculés pour chiens is a veterinary medicine in the form of comprimé pélliculé containing oclacitinib, intended for the following species: dog. It is marketed by ZOETIS BELGIUM S.A. It holds a marketing authorisation in Tunisia under number 195.1626.25.

Characteristics

Form

Comprimé pélliculé

Strength

5,4 mg

Presentation

Boite de 20 comprimés

Route of administration

Oral route

Laboratory

ZOETIS BELGIUM S.A

Country

BELGIQUE

Target species

Dog

Regulatory status — Tunisie

🟢 Marketing authorisation in force

Authorisation no. : 195.1626.25 — Authorisation date : 14/07/2025

⚠️ Regulatory alerts

No alert reported.

📦 Availability in Tunisia

Reported by TunisieVet veterinarians.

🔒 Availability reporting is reserved for signed-in veterinarians.